SV2009002971A - Enmascaramiento del sabor de polvos - Google Patents

Enmascaramiento del sabor de polvos

Info

Publication number
SV2009002971A
SV2009002971A SV2008002971A SV2008002971A SV2009002971A SV 2009002971 A SV2009002971 A SV 2009002971A SV 2008002971 A SV2008002971 A SV 2008002971A SV 2008002971 A SV2008002971 A SV 2008002971A SV 2009002971 A SV2009002971 A SV 2009002971A
Authority
SV
El Salvador
Prior art keywords
flavor mask
dust
dust flavor
mask
administration
Prior art date
Application number
SV2008002971A
Other languages
English (en)
Spanish (es)
Inventor
Rainer Bellinghausen
Daniel Rudhardt
Frank Ridder
Martin Steinbeck
Jesko Zank
Martin Weiss
Olaf Behrend
Stiphout Udo Van
Original Assignee
Bayer Technology Services Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Technology Services Gmbh filed Critical Bayer Technology Services Gmbh
Publication of SV2009002971A publication Critical patent/SV2009002971A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SV2008002971A 2005-12-24 2008-06-23 Enmascaramiento del sabor de polvos SV2009002971A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005062270A DE102005062270A1 (de) 2005-12-24 2005-12-24 Geschmacksmaskierung von Pulvern

Publications (1)

Publication Number Publication Date
SV2009002971A true SV2009002971A (es) 2009-04-28

Family

ID=38042692

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2008002971A SV2009002971A (es) 2005-12-24 2008-06-23 Enmascaramiento del sabor de polvos

Country Status (24)

Country Link
US (1) US20090269411A1 (https=)
EP (1) EP1968555A2 (https=)
JP (2) JP5275039B2 (https=)
KR (2) KR101245627B1 (https=)
CN (1) CN101346133A (https=)
AU (1) AU2006331009B2 (https=)
BR (1) BRPI0620618A2 (https=)
CA (1) CA2634481A1 (https=)
CR (1) CR10112A (https=)
CU (1) CU23877B1 (https=)
DE (1) DE102005062270A1 (https=)
EC (1) ECSP088577A (https=)
GT (1) GT200800126A (https=)
HN (1) HN2008000964A (https=)
IL (1) IL192085A0 (https=)
MA (1) MA30072B1 (https=)
MY (1) MY149601A (https=)
NZ (1) NZ569279A (https=)
RU (1) RU2440103C2 (https=)
SV (1) SV2009002971A (https=)
TN (1) TNSN08284A1 (https=)
UA (1) UA93072C2 (https=)
WO (1) WO2007073911A2 (https=)
ZA (1) ZA200805498B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
NZ586666A (en) * 2008-02-13 2012-04-27 Bayer Schering Pharma Ag Estradiol-containing drug delivery system
EA018330B1 (ru) * 2008-02-13 2013-07-30 Байер Интеллекчуал Проперти Гмбх Система доставки лекарственного средства со стабилизирующим эффектом
AU2009321822B2 (en) * 2008-12-05 2015-04-16 Elanco Animal Health Gmbh Extrudate having spicular active substances
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
UY32836A (es) * 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
US20120207836A1 (en) 2009-08-19 2012-08-16 Bayer Pharma Aktiengesellschaft Drug delivery systems (wafer) for pediatric use
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
US9084976B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
AU2011305572B2 (en) 2010-09-20 2016-08-04 Diane Goll Microencapsulation process and product
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
WO2016067132A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix
CN114993892B (zh) * 2019-05-13 2024-10-18 南京制药厂有限公司 吡喹酮粒度的光散射检测法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
KR20010042547A (ko) * 1998-04-09 2001-05-25 유란드 인터내셔날 에스.피.아. 소수성 폴리머로 코팅된 코어를 갖는 습윤성 마이크로캡슐
FR2811913B1 (fr) * 2000-07-19 2003-09-19 Separex Sa Procede d'encapsulation sous forme de micro-capsules de fines particules solides
GB2405798A (en) * 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.

Also Published As

Publication number Publication date
NZ569279A (en) 2011-06-30
CR10112A (es) 2009-01-07
AU2006331009B2 (en) 2012-10-04
DE102005062270A1 (de) 2007-06-28
ECSP088577A (es) 2008-07-30
JP5275039B2 (ja) 2013-08-28
RU2008130171A (ru) 2010-01-27
BRPI0620618A2 (pt) 2011-11-16
TNSN08284A1 (en) 2009-10-30
JP2013144695A (ja) 2013-07-25
KR20120006085A (ko) 2012-01-17
JP2009521419A (ja) 2009-06-04
MA30072B1 (fr) 2008-12-01
EP1968555A2 (de) 2008-09-17
HN2008000964A (es) 2013-03-11
ZA200805498B (en) 2009-11-25
MY149601A (en) 2013-09-13
AU2006331009A1 (en) 2007-07-05
WO2007073911A2 (de) 2007-07-05
CN101346133A (zh) 2009-01-14
UA93072C2 (ru) 2011-01-10
US20090269411A1 (en) 2009-10-29
IL192085A0 (en) 2008-12-29
CA2634481A1 (en) 2007-07-05
WO2007073911A3 (de) 2007-08-23
KR101245627B1 (ko) 2013-03-20
CU23877B1 (es) 2013-04-19
KR20080081021A (ko) 2008-09-05
GT200800126A (es) 2010-06-25
CU20080124A7 (es) 2010-08-30
RU2440103C2 (ru) 2012-01-20

Similar Documents

Publication Publication Date Title
SV2009002971A (es) Enmascaramiento del sabor de polvos
UY27218A1 (es) Formulaciones de polvos para inhalación
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
WO2008066899A3 (en) Nanoparticulate formulations and methods for the making and use thereof
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
ITMI20051999A1 (it) Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
WO2007016563A3 (en) Alcohol resistant pharmaceutical formulations
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
CL2008001820A1 (es) Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer.
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
MX2010005036A (es) Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
IL197783A (en) Polycyclic compounds, preparations containing them and polycyclic compounds for use in the treatment of synthetic respiratory virus infections
ATE399543T1 (de) Neue synergistische zusammensetzung enthaltend roflumilast und formoterol
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
BRPI0820659A2 (pt) composto, prodroga de composto, composição farmacêutica e formulação oral e uso de composto.
PE20091075A1 (es) Etanolato de n-[4-(3-amino-1h-indazol-4-il)fenil]-n'-(2-fluoro-5-metilfenil)urea.1/4 cristalino y formulaciones que lo comprenden
CY1106013T1 (el) Ρινικη φαρμακευτικη συνθεση της πepιβεδιλης
BRPI0618370A2 (pt) formulação aerossol de medicamento, uso do mesmo e kit de inalação